Investigation of the safety and efficacy of Budesonide ( Zentacort Capsules ) in patients with Crohn's disease
Not Applicable
Recruiting
- Conditions
- Crohn's disease
- Registration Number
- JPRN-jRCT1080224091
- Lead Sponsor
- ZERIA Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
mild to moderate active Crohn's disease in patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method